Physician profile
Alexi Laursen
NPI 1982010104
$2,133.39
in general payments reported to CMS, 2019-2025
13 companies · $118 in 2025
The $118 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $613 · 2023: $790 · 2024: $612 · 2025: $118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,520.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,520.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $499.63 | 2022-2024 | Tagrisso, Imfinzi, Enhertu |
| Janssen Biotech, INC. | $309.41 | 2023-2025 | Tecvayli, Darzalex, Rybrevant |
| Genentech USA, INC. | $204.68 | 2023-2024 | Lunsumio |
| Seagen INC. | $181.07 | 2022-2023 | Tukysa |
| Myovant Sciences INC. | $176.58 | 2022 | |
| Pharmacyclics LLC, An Abbvie Company | $137.63 | 2023 | Imbruvica |
| Incyte Corporation | $129.06 | 2023 | Jakafi |
| E.R. Squibb & Sons, L.L.C. | $121.24 | 2023 | Opdivo |
| Puma Biotechnology, INC. | $97.43 | 2022 | |
| Daiichi Sankyo INC. | $93.19 | 2022 | |
| Foundation Medicine, INC. | $71.63 | 2022 | |
| Beigene USA, INC. | $64.61 | 2023 | Brukinsa |
| Abbvie INC. | $47.23 | 2024-2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexi Laursen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.